These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 2681428)
1. Delta infection and drug abuse in Merseyside. Turner GC; Panton N; Vandervelde EM J Infect; 1989 Sep; 19(2):113-8. PubMed ID: 2681428 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology of hepatitis D virus (delta) infection in Melbourne over a 15-year period. Dimitrakakis M; Waters MJ; Wootton AL; Gust ID Med J Aust; 1986 Aug 4-18; 145(3-4):128-30. PubMed ID: 3736476 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of delta infection in drug addicts in Valencia, Spain. Rodrigo JM; Serra MA; Gimeno V; Olmo JA; Aparisi L; Escudero A; Wassel AH; Bixquert M Prog Clin Biol Res; 1987; 234():407-8. PubMed ID: 3628399 [No Abstract] [Full Text] [Related]
4. Delta hepatitis in Malaysia. Sinniah M; Dimitrakakis M; Tan DS Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of delta infection in the western Pacific region. Dimitrakakis M; Crowe S; Gust I J Med Virol; 1986 Apr; 18(4):335-9. PubMed ID: 3011980 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B and D virus infection among drug abusers in Taiwan. Lee SD; Wang JY; Wu JC; Chiang YT; Tsai YT; Lo KJ J Med Virol; 1986 Nov; 20(3):247-52. PubMed ID: 3783132 [TBL] [Abstract][Full Text] [Related]
13. Current seroepidemiology of hepatitis D virus infection among hepatitis B surface antigen carriers of general and high-risk populations in Taiwan. Chen CJ; Tseng SF; Lu CF; Lin HC; You SL; Chen CS; Hwang SJ; Hsieh SF; Hsu ST J Med Virol; 1992 Oct; 38(2):97-101. PubMed ID: 1460460 [TBL] [Abstract][Full Text] [Related]
14. [Retrospective (1970-1984) serological study of delta antigen and antibody. Observations on seroconversion and absence of delta in non-A, non-B hepatitis]. Stroun J; Peitrequin R; Frei PC Schweiz Med Wochenschr; 1987 Feb; 117(9):307-14. PubMed ID: 3105053 [TBL] [Abstract][Full Text] [Related]
15. Epidemiological aspects of delta (HDV) infection in a northern Italy district. Magnani G; Calzetti C; Degli Antoni A; Perinotto P; Pasetti G Prog Clin Biol Res; 1987; 234():385-7. PubMed ID: 3628392 [No Abstract] [Full Text] [Related]
16. Prevalence of anti-delta antibodies in selected populations of HBsAg carriers in the Białystok region, Poland. Boroń P; Boroń-Kaczmarska A; Bobrowska E; Kamińska H; Lapiński W Prog Clin Biol Res; 1987; 234():427. PubMed ID: 3628403 [No Abstract] [Full Text] [Related]
17. The serology of delta hepatitis and the detection of IgM anti-HD by EIA using serum derived delta antigen. Shattock AG; Morris M; Kinane K; Fagan C J Virol Methods; 1989 Mar; 23(3):233-40. PubMed ID: 2654168 [TBL] [Abstract][Full Text] [Related]
18. Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan. Chung DC; Ko YC; Chen CJ; Chen ER; Wu CC; Wu PS J Med Virol; 1989 Aug; 28(4):215-8. PubMed ID: 2778445 [TBL] [Abstract][Full Text] [Related]
19. Contrasting prevalence of delta hepatitis markers in parenteral drug abusers with and without AIDS. Kreek MJ; Des Jarlais DC; Trepo CL; Novick DM; Abdul-Quader A; Raghunath J J Infect Dis; 1990 Aug; 162(2):538-41. PubMed ID: 2373877 [TBL] [Abstract][Full Text] [Related]
20. Clinical and epidemiological significance of hepatitis delta virus (HDV) infection in chronic HBV carriers in Portugal. Ramalho F; Carvalho G; Bonino F; Baptista A; de Moura MC Prog Clin Biol Res; 1987; 234():409-17. PubMed ID: 3628400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]